Archive for August 2024

AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema • Novel JEL™ Technology for Periocular Administration Costa Mesa, Calif.,…